I. Fogelman

G. Blake, I. Fogelman, R. Patel, 1999, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Survival analyses from the ZEBRA study. goserelin (Zoladex) versus CMF in premenopausal women with node-positive breast cancer.

J. Cuzick, W. Sauerbrei, R. Blamey, 2003, European journal of cancer.

Semiautomatic Region-of-Interest Validation at the Femur in 18F-Fluoride PET/CT

P. Marsden, H. Carr, N. Colgan, 2012, The Journal of Nuclear Medicine Technology.

Impact of bone mineral measurements on osteoporosis

G. Blake, I. Fogelman, A. Rodin, 2005, European Journal of Nuclear Medicine.

The Clinical Relevance of Bone Mass Measurements

I. Fogelman, A. Rodin, 1990 .

An evaluation of the contribution of bone mass measurements to clinical practice.

I. Fogelman, 1989, Seminars in nuclear medicine.

18F-fluoride Positron Emission Tomography Measurements of Regional Bone Formation in Hemodialysis Patients with Suspected Adynamic Bone Disease

M. Siddique, J. Compston, D. Goldsmith, 2013, Calcified Tissue International.

Differential effects of teriparatide on regional bone formation using 18F‐fluoride positron emission tomography

R. Eastell, P. Marsden, M. Siddique, 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Assessment of regional changes in skeletal metabolism following 3 and 18 months of teriparatide treatment

G. Blake, I. Fogelman, K. Taylor, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Dissociation Between Global Markers of Bone Formation and Direct Measurement of Spinal Bone Formation in Osteoporosis

P. Marsden, G. Cook, G. Blake, 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Cyclical Etidronate Therapy for Prevention of Postmenopausal Bone Loss: A 1-Year Open-Label Follow-Up Study

R. Balena, G. Blake, I. Fogelman, 2000, Calcified Tissue International.

Osteopaenia of the lumbar spine and femoral neck in anorexia nervosa.

J. Treasure, G. Russell, I. Fogelman, 1986, Scottish medical journal.

Reversible bone loss in anorexia nervosa.

J. Treasure, G. Russell, I. Fogelman, 1987, British medical journal.

Bone and soft tissue tumors

G. Cook, I. Fogelman, G. Gnanasegaran, 2007 .

Bone densitometry and the diagnosis of osteoporosis.

G. Blake, I. Fogelman, G M Blake, 2001, Seminars in nuclear medicine.

A comparison of bone mineral density in the spine, hip and jaws of edentulous subjects.

R. Palmer, G. Blake, I. Fogelman, 2007, Clinical oral implants research.

Methods and Clinical Issues in Bone Densitometry and Quantitative Ultrasonometry

G. Blake, I. Fogelman, 2002 .

Peripheral or central densitometry: does it matter which technique we use?

G. Blake, I. Fogelman, 2001, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Pagets disease of bone: Appearances with 18-FDG PET

G. Cook, I. Fogelman, M. Maisey, 1996 .

Radioiodine treatment of solitary functioning thyroid nodules.

I. Fogelman, M. Maisey, G. Ratcliffe, 1986, The British journal of radiology.

Occupational dose to the radiographer in dual X-ray absorptiometry: a comparison of pencil-beam and fan-beam systems.

G. Blake, I. Fogelman, R. Patel, 1996, The British journal of radiology.

Technetium-99m-labeled HL91 to identify tumor hypoxia: correlation with fluorine-18-FDG.

S. Barrington, I. Fogelman, S. Houston, 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Evaluation of aortic 18F-NaF tracer uptake using PET/CT as a predictor of aortic calcification in postmenopausal women: A longitudinal study

P. Chowienczyk, G. Blake, I. Fogelman, 2019, JRSM cardiovascular disease.

Value of SPECT/CT in the evaluation of knee pain.

I. Fogelman, G. Gnanasegaran, S. Vijayanathan, 2013, Clinical nuclear medicine.

Obesity increases precision errors in dual-energy X-ray absorptiometry measurements.

K. Knapp, J. Welsman, G. Blake, 2012, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

An Unexpected Change in DXA Calibration not Detected by Routine Quality Control Checks

G. Blake, I. Fogelman, R. Herd, 1999, Osteoporosis International.

Dual X-ray Absorptiometry

K. Knapp, G. Blake, I. Fogelman, 2005, Calcified Tissue International.

Multislice SPECT/CT in benign and malignant bone disease: when the ordinary turns into the extraordinary.

I. Fogelman, G. Gnanasegaran, T. Barwick, 2009, Seminars in nuclear medicine.

The identification of spinal pathology in chronic low back pain using single photon emission computed tomography.

I. Fogelman, R. Ryan, T. Gibson, 1992, Nuclear medicine communications.

Bone scintigraphy: Part 2. Orthopedic bone scanning.

M. Brown, I. Fogelman, B. D. Collier, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Bone SPECT in osteoid osteoma of the vertebral lamina.

I. Fogelman, P. Ryan, 1994, Clinical nuclear medicine.

SPET bone scanning can predict successful facet joint injection

I. Fogelman, P. Ryan, N. Arden, 1995 .

Skeletal Nuclear Medicine

I. Fogelman, L. Rosenthall, D. Collier, 1996 .

Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post‐menopausal women who have previously received long‐term oral oestrogens

M. Savvas, J. Studd, I. Fogelman, 1992 .

Fibroblast growth factor-23 is associated with C-reactive protein, serum phosphate and bone mineral density in chronic kidney disease

W. Fraser, A. Wierzbicki, D. Goldsmith, 2010, Osteoporosis International.

Monitoring treatment for osteoporosis by using bone densitometry.

G. Blake, I. Fogelman, 2001, Seminars in nuclear medicine.

The role of nuclear medicine in monitoring treatment in skeletal malignancy.

I. Fogelman, G. Cook, G. Cook, 2001, Seminars in nuclear medicine.

Bone mineral density in professional female dancers.

G. Blake, I. Fogelman, G. Blake, 1997, British journal of sports medicine.

Overview of the Role of Bone Scintigraphy in the Pathophysiology of Sporting Injuries

I. Fogelman, R. Mansberg, H. Wall, 2015 .

Soft Tissue Uptake in Radionuclide Bone Scintigraphy

I. Fogelman, G. Gnanasegaran, F. Hassan, 2012 .

Changes observed in radionuclide bone scans during and after teriparatide treatment for osteoporosis

G. Blake, I. Fogelman, V. Ruff, 2011, European Journal of Nuclear Medicine and Molecular Imaging.

Conventional measurements of GFR using 51Cr-EDTA overestimate true renal clearance by 10 percent

G. Blake, I. Fogelman, S. Park-Holohan, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Regional bone metabolism at the lumbar spine and hip following discontinuation of alendronate and risedronate treatment in postmenopausal women

R. Eastell, P. Marsden, M. Siddique, 2012, Osteoporosis International.

Pseudohypoparathyroidism presenting as severe Parkinsonism.

D. Pearson, I. Fogelman, G. Beastall, 1981, Postgraduate medical journal.

Nuclear Medicine Annual 2002

G. Cook, I. Fogelman, M. Maisey, 2002, European Journal of Nuclear Medicine and Molecular Imaging.

Investigation of Metabolic Bone Diseases (Section Editor: Pierre Delmas)

R. Recker, G. Cook, N. Bishop, 2008 .

Bone mineral content of women receiving tamoxifen for mastalgia.

I. Fentiman, M. Caleffi, I. Fogelman, 1989, British Journal of Cancer.

Hormone replacement therapy and serum angiotensin-converting-enzyme activity in postmenopausal women

I. Fogelman, A.I.H. Ahmed, J. Rymer, 1995, The Lancet.

The accuracy of volumetric bone density measurements in dual X-ray absorptiometry

G. Blake, I. Fogelman, M. Sabin, 1995, Calcified Tissue International.

Potential role of multislice SPECT/CT in impingement syndrome and soft-tissue pathology of the ankle and foot

S. Chicklore, I. Fogelman, G. Gnanasegaran, 2013, Nuclear medicine communications.

Bone mineral density in premenopausal women treated for node-positive early breast cancer with 2 years of goserelin or 6 months of cyclophosphamide, methotrexate and 5-fluorouracil (CMF)

W. Sauerbrei, R. Blamey, M. Schumacher, 2003, Osteoporosis International.

A UK Consensus Group on management of glucocorticoid‐induced osteoporosis: an update

C. Cooper, R. Francis, D. Torgerson, 1998, Journal of internal medicine.

Vitamin D Status and Parathyroid Hormone Concentrations Influence the Skeletal Response to Zoledronate and Denosumab

I. Fogelman, A. Moore, G. Hampson, 2014, Calcified Tissue International.

Clinical role of bisphosphonate therapy

I. Fogelman, G. Hampson, 2012, International journal of women's health.

The assessment of regional skeletal metabolism: studies of osteoporosis treatments using quantitative radionuclide imaging.

M. Siddique, G. Blake, I. Fogelman, 2011, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Could Strontium Ranelate Have a Synergistic Role in the Treatment of Osteoporosis?

J. Compston, G. Blake, I. Fogelman, 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The correction of BMD measurements for bone strontium content.

G. Blake, I. Fogelman, 2007, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Effect of bone strontium on BMD measurements.

G. Blake, I. Fogelman, 2007, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Theoretical Model for the Interpretation of BMD Scans in Patients Stopping Strontium Ranelate Treatment

G. Blake, I. Fogelman, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Long‐Term Effect of Strontium Ranelate Treatment on BMD

G. Blake, I. Fogelman, 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Dual X-ray absorptiometry: clinical evaluation of a new cone-beam system.

K. Knapp, G. Blake, I. Fogelman, 2005, Calcified tissue international.

Does the Combination of Two BMD Measurements Improve Fracture Discrimination?

K. Knapp, G. Blake, I. Fogelman, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Clinical use of instruments that measure peripheral bone mass

G. Blake, I. Fogelman, 2002 .

Bone densitometry, steroids and osteoporosis.

G. Blake, I. Fogelman, 2002, Current opinion in nephrology and hypertension.

Monitoring skeletal response to treatment which site to measure in the femur?

G. Blake, I. Fogelman, R. Herd, 2000, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Alendronate in early postmenopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study Group.

P. Sambrook, J. Rodriguez-Portales, G. Fuleihan, 2000, The Journal of clinical endocrinology and metabolism.

Intermittent Oral Disodium Pamidronate in Established Osteoporosis: A 2 Year Double-Masked Placebo-Controlled Study of Efficacy and Safety

G. Blake, I. Fogelman, P. Ryan, 2000, Osteoporosis International.

Screening for osteoporosis

I. Fogelman, 1999, BMJ.

A comparison of a peripheral DXA system with conventional densitometry of the spine and femur.

A. Jefferies, G. Blake, I. Fogelman, 1998, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

The future of bone density measurements

G. Blake, I. Fogelman, 1997, European Journal of Nuclear Medicine.

Risedronate Reduces the Risk of First Vertebral Fracture in Osteoporotic Women

P. Geusens, R. Heaney, I. Fogelman, 2002, Osteoporosis International.

Skeletal metastases from breast cancer: imaging with nuclear medicine.

I. Fogelman, G. Cook, I. Fogelman, 1999, Seminars in nuclear medicine.

Osteocalcin: a potential marker of metastatic bone disease and response to treatment.

M. Caleffi, R. Rubens, R. Coleman, 1988, European journal of cancer & clinical oncology.

Detection of bone metastases in cancer patients by 18F-fluoride and 18F-fluorodeoxyglucose positron emission tomography.

I. Fogelman, G. Cook, G. Cook, 2001, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

Reappraisal of the baseline bone scan in breast cancer.

R. Rubens, R. Coleman, I. Fogelman, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

FDG-PET as a "metabolic biopsy" tool in thoracic lesions with indeterminate biopsy

S. Hain, M. O'Doherty, K. Curran, 2001, European Journal of Nuclear Medicine.

The added value of multislice SPECT/CT in patients with equivocal bony metastasis from carcinoma of the prostate

L. Livieratos, I. Fogelman, G. Gnanasegaran, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

Effects of dietary improvement on bone metabolism in elderly underweight women with osteoporosis: a randomised controlled trial

F. Martin, S. Sankaralingam, G. Blake, 2003, Osteoporosis International.

The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women.

G. Blake, I. Fogelman, M. Frost, 2013, Bone.

Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions.

R. Rubens, I. Fogelman, M. Maisey, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

FDG-PET and CT patterns of bone metastases and their relationship to previously administered anti-cancer therapy

Z. Keidar, O. Israel, I. Fogelman, 2006, European Journal of Nuclear Medicine and Molecular Imaging.

Osteoblastic bone metastases in breast cancer: is not seeing believing?

I. Fogelman, 2005, European Journal of Nuclear Medicine and Molecular Imaging.

Bone scanning in clinical oncology: does it have a future?

I. Fogelman, A. Jacobson, 1998, European Journal of Nuclear Medicine.

The ultrasonic assessment of osteopenia as defined by dual X-ray absorptiometry.

G. Blake, I. Fogelman, R. Herd, 1994, The British journal of radiology.

A comparison of reference bone mineral density measurements derived from two sources: referred and population based.

T. Spector, G. Blake, I. Fogelman, 1993, The British journal of radiology.

Measurement of bone mass.

I. Fogelman, P. Ryan, 1992, Bone.

The value of SPECT scans in identifying back pain likely to benefit from facet joint injection.

N. Arden, I. Fogelman, P. Ryan, 1996, British journal of rheumatology.

Bone scintigraphy in benign bone disease.

J. Mckillop, I. Fogelman, I. Fogelman, 1984, British medical journal.

Long term compliance with hormone replacement treatment following screening for postmenopausal osteoporosis by bone density measurements

G. Blake, I. Fogelman, P. Ryan, 1996 .

Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. BMD-MN Study Group.

J. Reginster, I. Fogelman, C. Ribot, 2000, The Journal of clinical endocrinology and metabolism.

Lung scanning for pulmonary embolism: clinical and pulmonary angiographic correlations.

J. Mckillop, I. Fogelman, F. Moran, 1990, The Quarterly journal of medicine.

Osteosarcomatous metaplastic carcinoma of the breast with metaplastic changes seen in lymph node metastasis: A case history and review of imaging findings

P. Cane, I. Fogelman, V. Raman, 2008 .

Radionuclide studies of bone metabolism: do bone uptake and bone plasma clearance provide equivalent measurements of bone turnover?

M. Siddique, G. Blake, I. Fogelman, 2011, Bone.

A Prospective Study of Risedronate on Regional Bone Metabolism and Blood Flow at the Lumbar Spine Measured by18F‐Fluoride Positron Emission Tomography

P. Marsden, G. Cook, G. Blake, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A Prospective Study of Risedronate on Regional Bone Metabolism and Blood Flow at the Lumbar Spine Measured by 18 F-Fluoride Positron

P. Marsden, G. Cook, G. Blake, 2003 .

Changes in RANKL/OPG/RANK gene expression in peripheral mononuclear cells following treatment with estrogen or raloxifene

S. Sankaralingam, I. Fogelman, A. Grigoriadis, 2005, Steroids.

Where now for the management of osteoporosis?

I. Fogelman, 2005, Hospital medicine.

Interleukin-6 (IL-6), IL-1, receptor activator of nuclear factor kappaB ligand (RANKL) and osteoprotegerin production by human osteoblastic cells: comparison of the effects of 17-beta oestradiol and raloxifene.

B. Evans, I. Fogelman, Y. Mak, 2003, The Journal of endocrinology.

Premenopausal bone loss in the lumbar spine and neck of femur: a study of 225 Caucasian women.

I. Fentiman, M. Caleffi, I. Fogelman, 1990, Bone.

Fracture thresholds in osteoporosis: implications for hormone replacement treatment.

G. Blake, I. Fogelman, P. Ryan, 1992, Annals of the rheumatic diseases.

Measurement of forearm bone mineral density in normal women by dual-energy X-ray absorptiometry.

G. Blake, I. Fogelman, P. Ryan, 1992, The British journal of radiology.

Clinical experience with etidronate in osteoporosis

I. Fogelman, P. Ryan, 1994, Clinical Rheumatology.

Effect of tibolone on postmenopausal bone loss

I. Fogelman, J. Rymer, M. Chapman, 1994, Osteoporosis International.

The prevention of early postmenopausal bone loss by cyclical etidronate therapy: a 2-year, double-blind, placebo-controlled study.

R. Balena, G. Blake, I. Fogelman, 1997, The American journal of medicine.

Clinical experience with etidronate

I. Fogelman, P. Ryan, 1993 .

The Measurement of Bone Density

I. Fogelman, A. Rodin, 1990 .

3 Bone scanning and photon absorptiometry in metabolic bone disease

I. Fogelman, 1988 .

The Bone Scan in Metabolic Bone Disease

I. Fogelman, 1987 .

The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis

I. Fogelman, G. Hampson, A. Deane, 2007, BMC musculoskeletal disorders.

The value of bone scintigraphy in the evaluation of osteoporotic patients with back pain

I. Fogelman, S. Clarke, G. Cook, 2002, Scandinavian journal of rheumatology.

Effect of a 300 000-IU loading dose of ergocalciferol (Vitamin D2) on circulating 1,25(OH)2-vitamin D and fibroblast growth factor-23 (FGF-23) in vitamin D insufficiency.

W. Fraser, I. Fogelman, N. Dalton, 2013, The Journal of clinical endocrinology and metabolism.

Differences in Skeletal Kinetics Between Vertebral and Humeral Bone Measured by 18F‐Fluoride Positron Emission Tomography in Postmenopausal Women

P. Marsden, M. Lodge, G. Blake, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Gonadotropin-releasing hormone agonists and the skeleton.

I. Fogelman, 1992, Fertility and sterility.

Bone: Strontium ranelate does not have an anabolic effect on bone

G. Blake, I. Fogelman, 2013, Nature Reviews Endocrinology.

Absolute fracture risk varies with bone densitometry technique used. A theoretical and in vivo study of fracture cases.

K. Knapp, G. Blake, I. Fogelman, 2002, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Peripheral and Central Measurements of Bone Mineral Density Are Equally Strongly Associated with Clinical Risk Factors for Osteoporosis

G. Blake, I. Fogelman, R. Patel, 2007, Calcified Tissue International.

Multisite Quantitative Ultrasound: Colles’ Fracture Discrimination in Postmenopausal Women

K. Knapp, G. Blake, I. Fogelman, 2002, Osteoporosis International.

An Investigation of Unique and Shared Gene Effects on Speed of Sound and Bone Density Using Axial Transmission Quantitative Ultrasound and DXA in Twins

T. Spector, K. Knapp, G. Blake, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

59. Patient dosimetry studies on the hologic QDR-1000 and QDR-1000/W

G. Blake, I. Fogelman, M. K. Lewis, 1992 .

Quantitative Measurements of Bone Remodeling Using 99mTc-Methylene Diphosphonate Bone Scans and Blood Sampling

G. Blake, I. Fogelman, A. Moore, 2008, Journal of Nuclear Medicine.

Can the WHO definition of osteoporosis be applied to multi-site axial transmission quantitative ultrasound?

T. Spector, K. Knapp, G. Blake, 2004, Osteoporosis International.

Differential effects of hormone replacement therapy on bone mineral density and axial transmission ultrasound measurements in cortical bone

T. Spector, K. Knapp, G. Blake, 2003, Osteoporosis International.

A clinical profile of back pain and disability in patients with spinal osteoporosis.

I. Fogelman, G. Blake, R. Herd, 1994, Bone.

Osteoporosis and chronic back pain: A study with single‐photon emission computed tomography bone scintigraphy

M. Liebert, I. Fogelman, P. Ryan, 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone single photon emission computed tomography

G. Cook, I. Fogelman, 2001 .

Bone scintigraphy in metabolic bone disease.

I. Fogelman, P. Ryan, 1997, Seminars in nuclear medicine.

Spinal bone SPECT in chronic symptomatic ankylosing spondylitis.

I. Fogelman, P. Ryan, T. Gibson, 1997, Clinical nuclear medicine.

28. Facet joint injection in patients with low back pain and increased facetal joint activity on bone scintigraphy with SPECT: a pilot study

I. Fogelman, P. Ryan, T. Gibson, 1992 .

18F‐fluoride PET as a noninvasive imaging biomarker for determining treatment efficacy of bone active agents at the hip: A prospective, randomized, controlled clinical study

P. Marsden, M. Siddique, P. Schleyer, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Circulating Fibroblast Growth Factor-23 Increases Following Intermittent Parathyroid Hormone (1–34) in Postmenopausal Osteoporosis: Association with Biomarker of Bone Formation

W. Fraser, I. Fogelman, M. Frost, 2010, Calcified Tissue International.

SPECT bone scintigraphy of anterior cruciate ligament injury.

I. Fogelman, P. Ryan, S. Clarke, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Skeletal Tracer Kinetics: Science and Practice

M. Siddique, G. Blake, I. Fogelman, 2012 .

Quantitative Radionuclide Studies of Bone

G. Blake, I. Fogelman, M. Frost, 2009, Journal of Nuclear Medicine.

Quantitative studies of bone using 18F-fluoride and 99mTc-methylene diphosphonate: evaluation of renal and whole-blood kinetics

G. Blake, I. Fogelman, S. Park-Holohan, 2001, Nuclear medicine communications.

Focal osteomalacia due to “low dose” diphosphonate therapy in paget's disease

S. Ralston, B. Boyce, I. Fogelman, 1984 .

Does the Combination of Quantitative Ultrasound and Dual-Energy X-Ray Absorptiometry Improve Fracture Discrimination?

G. Blake, I. Fogelman, M. Frost, 2001, Osteoporosis International.

The Effect of Season and Vitamin D Supplementation on Bone Mineral Density in Healthy Women: A Double-Masked Crossover Study

R. Swaminathan, G. Blake, I. Fogelman, 2001, Osteoporosis International.

Effect of a GnRH analogue on bone mass in premenopausal patients with mastalgia

I. Fentiman, W. Gregory, I. Fogelman, 1993 .

BONE MASS IN HIRSUTE WOMEN WITH ANDROGEN EXCESS

I. Fogelman, A. Rodin, B. Murby, 1989, Clinical endocrinology.

The role of positron emission tomography in the management of bone metastases

I. Fogelman, I Fogelman, G J Cook, 2000, Cancer.

FOCAL OSTEOMALACIA DUE TO LOW-DOSE DIPHOSPHONATE THERAPY IN PAGET'S DISEASE

S. Ralston, B. Boyce, I. Fogelman, 1984, The Lancet.

Single infusion of zoledronate in Paget's disease of bone: a placebo-controlled, dose-ranging study.

P. Richardson, E. Siris, D. Hosking, 1999, Bone.

The Bone Scan in Metastatic Disease

J. Mckillop, I. Fogelman, 1991 .

Bone secondaries in breast cancer: the solitary metastasis.

R. Coleman, I. Fogelman, C. Todd, 1989, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Bone Secondariesin BreastCancer: The SolitaryMetastasis

R. Coleman, I. Fogelman, C. Todd, 1989 .

Bone radionuclide imaging, quantitation and bone densitometry

G. Blake, I. Fogelman, 2016 .

Differences in regional bone metabolism at the spine and hip: a quantitative study using 18F-fluoride positron emission tomography

P. Marsden, M. Siddique, K. Curran, 2013, Osteoporosis International.

Validation of new image-derived arterial input functions at the aorta using 18F-fluoride positron emission tomography

P. Marsden, M. Siddique, K. Curran, 2011, Nuclear medicine communications.

Validation of ultrafiltration as a method of measuring free 99mTc-MDP.

S. Hain, G. Blake, I. Fogelman, 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Quantification of Skeletal Kinetic Indices in Paget's Disease Using Dynamic18F‐Fluoride Positron Emission Tomography

P. Marsden, G. Cook, G. Blake, 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Bone Scintigraphy: Patterns, Variants, Limitations and Artefacts

I. Fogelman, G. Gnanasegaran, K. Adamson, 2012 .

The role of bone scanning in Paget's disease.

I. Fogelman, D. Carr, I. Boyle, 1981, Metabolic bone disease & related research.

Bone Scanning and 24-Hour Whole Body Retention of Diphosphonate in the Evaluation of Metabolic Bone Disease

I. Fogelman, R. Bessent, 1981 .

The Bone Scan in Clinical Practice

I. Fogelman, I. Boyle, 1980, Scottish medical journal.

Fluorine-18-FDG PET in Paget's disease of bone.

I. Fogelman, M. Maisey, G. Cook, 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Hypercalcaemia and breast cancer--an increased humoral component in patients with liver metastases.

R. Rubens, R. Coleman, I. Fogelman, 1988, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Selection of patients with breast cancer for routine follow-up bone scans.

R. Rubens, R. Coleman, I. Fogelman, 1990, Clinical oncology (Royal College of Radiologists (Great Britain)).

Bone scan flare predicts successful systemic therapy for bone metastases.

D. W. Moss, R. Rubens, R. Coleman, 1988, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The flare phenomenon: still learning after 35 years

I. Fogelman, 2010, European Journal of Nuclear Medicine and Molecular Imaging.

Primer on the metabolic bone diseases and disorders of mineral metabolism

G. Cook, I. Fogelman, 2003 .

Skeletal effects of oral oestrogen compared with subcutaneous oestrogen and testosterone in postmenopausal women.

M. Savvas, J. Studd, I. Fogelman, 1988, BMJ.

Beware of the focal uptake at the ischium on the bone scan in prostate cancer

I. Fogelman, G. Gnanasegaran, S. Vijayanathan, 2011, Nuclear medicine communications.

A prospective study of risedronate on regional bone metabolism and blood flow at the lumbar spine measured by 18F-fluoride positron emission tomography.

P. Marsden, G. Cook, G. Blake, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The Use of F-18 Choline PET in the Assessment of Bone Metastases in Prostate Cancer: Correlation with Morphological Changes on CT

Josef Hammer, Mohsen Beheshti, Reza Vali, 2010, Molecular Imaging and Biology.

SPECT/CT in imaging foot and ankle pathology-the demise of other coregistration techniques.

I. Fogelman, G. Gnanasegaran, S. Vijayanathan, 2010, Seminars in nuclear medicine.

Ultrasonic velocity measurements through the calcaneus: Which velocity should be measured?

G. Blake, I. Fogelman, R. Herd, 2005, Osteoporosis International.

Comparison of 10 versus 20 min SPECT 99mTc-MDP bone scans: use of 3D-OSEM image reconstruction with distance-dependent resolution modelling

L. Livieratos, I. Fogelman, G. Gnanasegaran, 2010, Nuclear medicine communications.

Registration Bone Scan in the Evaluation of Wrist Pain

J. D. Spencer, I. Fogelman, P. Ryan, 1997 .

Registration bone scan in the evaluation of wrist pain.

J. D. Spencer, I. Fogelman, P. Ryan, 1993, Journal of hand surgery.

A study of the early and late 99technetium scintigraphic images and their relationship to symptoms in osteoarthritis of the hands.

J. Lynch, J. Buckland-Wright, D. Macfarlane, 1993, British journal of rheumatology.

The role of nuclear medicine in orthopaedics

I. Fogelman, P. Ryan, 1994, Nuclear medicine communications.

Bone scintigraphy following intravenous pamidronate for Paget's disease of bone.

I. Fogelman, P. Ryan, T. Gibson, 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.

W. Greig, D. Citrin, I. Fogelman, 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Treatment of Paget's disease by weekly infusions of 3-aminohydroxypropylidene-1,1-bisphosphonate (APD).

I. Fogelman, P. Ryan, M. Sherry, 1992, British journal of rheumatology.

The relationship between the female menopause and serum sialic acid, a known cardiovascular risk factor.

A. Treloar, I. Fogelman, M. Crook, 1998, European journal of obstetrics, gynecology, and reproductive biology.

The prognostic and therapeutic implications of the positive radionuclide bone scan in clinically early breast cancer

W. Greig, D. Citrin, J. Mckillop, 1978, The British journal of surgery.

Scintigraphy in metabolic bone disease

G. Cook, I. Fogelman, 2003 .

Hypercalcaemia of malignancy: evidence for a nonparathyroid humoral agent with an effect on renal tubular handling of calcium.

S. Ralston, I. Fogelman, R. Cowan, 1984, Clinical science.

Serum concentrations of alkaline phosphatase isoenzymes and osteocalcin in normal pregnancy.

I. Fogelman, A. Rodin, J. Stevenson, 1989, The Journal of clinical endocrinology and metabolism.

Goserelin (Zoladex) and the skeleton

I. Fentiman, J. Studd, I. Fogelman, 1994, British journal of obstetrics and gynaecology.

Successful localisation of parathyroid adenomata by thallium-201 and technetium-99m subtraction scintigraphy: description of an improved technique

J. Mckillop, I. Fogelman, H. Gray, 2004, European Journal of Nuclear Medicine.

Tumor hypoxia: the role of nuclear medicine.

I. Fogelman, G. Cook, 1998, European journal of nuclear medicine.

A dose-controlled study of 153Sm-ethylenediaminetetramethylenephosphonate (EDTMP) in the treatment of patients with painful bone metastases.

R. Rubens, J. Chatal, I. Fogelman, 1997, European journal of cancer.

Vitamin D and bone mineral density

R. Swaminathan, I. Fogelman, C. Jasani, 2007, Osteoporosis International.

Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis

G. Blake, I. Fogelman, P. Ryan, 1992, British journal of obstetrics and gynaecology.

DEAFNESS DUE TO HYPERVITAMINOSIS D

I. Fogelman, H. Cohen, I. Boyle, 1979, The Lancet.

COLIA1 Sp1 Polymorphism Predicts Response of Femoral Neck Bone Density to Cyclical Etidronate Therapy

G. Blake, I. Fogelman, R. Herd, 2002, Calcified Tissue International.

Radionuclide measurement of right ventricular function in atrial septal defect, ventricular septal defect and complete transposition of the great arteries.

M. Tynan, I. Fogelman, E. Baker, 1986, The American journal of cardiology.

Bone Mineral Density and Its Relationship to Prolactin Levels in Patients Taking Antipsychotic Treatment

R. Murray, O. Howes, M. Wheeler, 2005, Journal of clinical psychopharmacology.

A study of the effect of tibolone on the vagina in postmenopausal women.

I. Fogelman, J. Rymer, M. Chapman, 1994, Maturitas.

CLINICAL VALUE OF ADRENAL ANDROGEN MEASUREMENT IN THE DIAGNOSIS OF DELAYED PUBERTY

I. Fogelman, G. Beastall, J. Thomson, 1981, The Lancet.

Insulin-like growth factor-I and bone mineral density.

R. Swaminathan, I. Fogelman, G. Blake, 1998, Bone.

Thyroid hormone and parathyroid hormone competing to maintain calcium levels in the presence of vitamin D deficiency.

A. Groves, I. Fogelman, S. Clarke, 2004, Thyroid : official journal of the American Thyroid Association.

Review of 3,530 referrals for bone density measurements of spine and femur: evidence that radiographic osteopenia predicts low bone mass.

G. Blake, I. Fogelman, J. Rymer, 1998, Radiology.

Postmenopausal screening for osteopenia.

G. Blake, I. Fogelman, P. Ryan, 1992, British journal of rheumatology.

Osteopetrosis: Radiological & Radionuclide Imaging

I. Fogelman, G. Gnanasegaran, K. Agrawal, 2015, Indian journal of nuclear medicine : IJNM : the official journal of the Society of Nuclear Medicine, India.

Principles of bone biology Vol 2

G. Blake, I. Fogelman, 2002 .

Comparison of simultaneous 99mTc-HMPAO and 111In oxine labelled white cell scans in the assessment of inflammatory bowel disease

I. Fogelman, G. Sladen, R. Allan, 1993, European Journal of Nuclear Medicine.

The effect of progestagens and tibolone on bone

I. Fogelman, J. Rymer, 1993 .

A LOW DOSE REGIME OF 1α HYDROXYVITAMIN D3 IN THE MANAGEMENT OF SENILE OSTEOPOROSIS: A PILOT STUDY

I. Fogelman, W. Mcintosh, G. Beastall, 1980, Clinical endocrinology.

Effect of subdermal oestrogen and oestrogen/testosterone implants on calcium and phosphorus homeostasis after oophorectomy.

S. Ralston, D. Barlow, C. Fletcher, 1984, Maturitas.

The relationship between pro-resorptive inflammatory cytokines and the effect of high dose vitamin D supplementation on their circulating concentrations.

I. Fogelman, N. Dalton, Y. Karim, 2013, International immunopharmacology.

Effect of etidronate disodium on bone turnover following surgical menopause

J. Bevan, I. Fogelman, D. Hart, 1989, Calcified Tissue International.

BONE MASS AFTER WITHDRAWAL OF OESTROGEN REPLACEMENT

R. Lindsay, I. Fogelman, D. Hart, 1981, The Lancet.

Effects of 8 Years of Treatment with Tibolone 2.5 mg Daily on Postmenopausal Bone Loss

J. Robinson, I. Fogelman, J. Rymer, 2001, Osteoporosis International.

Do Anticonvulsant Drugs Commonly Induce Osteomalacia?

B. F. Allam, B. Boyce, I. Fogelman, 1982, Scottish medical journal.

The relationship between plasma estradiol and the increase in bone density in postmenopausal women after treatment with subcutaneous hormone implants.

M. Savvas, J. Studd, I. Fogelman, 1990, American journal of obstetrics and gynecology.

I. Fogelman, 1982 .

Dual X-ray absorptiometry of the lumbar spine: the precision of paired anteroposterior/lateral studies.

G. Blake, I. Fogelman, R. Herd, 1994, The British journal of radiology.

Solid-phase synthesis of peptide radiopharmaceuticals using Fmoc-N-epsilon-(hynic-Boc)-lysine, a technetium-binding amino acid: application to Tc-99m-labeled salmon calcitonin.

P. Blower, I. Fogelman, K. Howland, 2003, Journal of medicinal chemistry.

Screening for Osteopenia and Osteoporosis: Do the Accepted Normal Ranges Lead to Overdiagnosis?

G. Blake, I. Fogelman, A.I.H. Ahmed, 1997, Osteoporosis International.

The effect of 1α‐hydroxyvitamin D3 on the mineralization defect in disodium etidronate‐treated paget's disease — a double‐blind randomized clinical study

S. Ralston, B. Boyce, I. Fogelman, 1987 .

Low circulating estradiol and adrenal androgens concentrations in men on glucocorticoids: a potential contributory factor in steroid-induced osteoporosis.

P. Seed, I. Fogelman, G. Hampson, 2002, Metabolism: clinical and experimental.

31. Physiological variants in 18FDG PET scanning: Potential for error in interpretation

G. Cook, I. Fogelman, M. Maisey, 1996 .

Osteoporosis: the clinical problem.

I. Fogelman, 1986, Scottish medical journal.

Tamoxifen protects against steroid-induced bone loss.

I. Fentiman, M. Caleffi, I. Fogelman, 1992, European journal of cancer.

F-18 FDG Positron Emission Tomography and Benign Fractures

I. Fogelman, I. H. Shon, Ignac Fogelman, 2003, Clinical nuclear medicine.

Scintigraphy of benign bone disease.

I. Fogelman, H. Van der Wall, 2007, Seminars in musculoskeletal radiology.

Hormone Binding Globulins and Anticonvulsant Therapy

I. Fogelman, R. Cowan, J. Gray, 1985, Scottish medical journal.

Diphosphonate bone scanning agents — Current concepts

I. Fogelman, 2004, European Journal of Nuclear Medicine.

99mTc Diphosphonate Bone-scanning Agents

I. Fogelman, 1987 .

99mTc Diphosphonate Uptake Mechanism on Bone

I. Fogelman, M. Francis, 1987 .

The Bone Scan in Paget’s Disease

I. Fogelman, 1987 .

Facts and Artefacts in Bone Densitometry

G. Blake, I. Fogelman, G. Gnanasegaran, 2007 .

Scintigraphy and treatment of medullary carcinoma of the thyroid with iodine-131 metaiodobenzylguanidine.

I. Fogelman, M. Maisey, B. Murby, 1987, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Can dual-energy x-ray absorptiometry-based hip structural analysis be used in patients treated with strontium ranelate?

G. Blake, I. Fogelman, 2012, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

A comparison of bone scanning and radiology in the assessment of patients with symptomatic Paget's disease

I. Fogelman, D. Carr, 1980, European Journal of Nuclear Medicine.

Radionuclide Imaging of the Hand and Wrist

B. Povlsen, I. Fogelman, G. Gnanasegaran, 2013 .

Wrist Registration: Conventional Radionuclide and SPECT/CT Imaging

B. Povlsen, P. Jackson, I. Fogelman, 2012 .

Skeletal uptake of diphosphonate: A review

I. Fogelman, 1980, European Journal of Nuclear Medicine.

The Bone Scan—Historical Aspects

I. Fogelman, 1987 .

HYPERCALCAEMIC OSTEOMALACIA DUE TO ALUMINIUM TOXICITY

H. Y. Elder, G. S. Fell, B. Boyce, 1982, The Lancet.

DIPHOSPHONATES AND INHIBITION OF BONE MINERALISATION

S. Ralston, B. Boyce, I. Fogelman, 1982, The Lancet.

Prevalence of inappropriate drug treatment in patients with hyperthyroidism

I. Fogelman, M. Maisey, G. Ratcliffe, 1986, British medical journal.

A clinical comparison of Tc-99m HEDP and Tc-99m MDP in the detection of bone metastases: concise communication.

W. Greig, D. Citrin, J. Mckillop, 1979, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A Clinical Comparison of 99mTc-Hydroxyethylidene Diphosphonate (H.E.D.P.) and 99mTc-Pyrophosphate in the Detection of Bone Metastases

D. Citrin, J. Mckillop, I. Fogelman, 1977 .

Radionuclide and Hybrid Bone Imaging

G. Blake, I. Fogelman, 2012 .

Direct labelling via simultaneous reduction of pertechnetate and a disulfide bond.

P. Blower, I. Fogelman, W. Greenland, 2002 .

The relationship between gonadotrophins, gonadal hormones and bone mass in men

A. Wierzbicki, I. Fogelman, A. Dolan, 2008, Clinical endocrinology.

Association of bone turnover markers and arterial stiffness in pre-dialysis chronic kidney disease (CKD).

M. Shearer, P. Chowienczyk, A. Wierzbicki, 2011, Bone.

Thyroid function in normal pregnancy

I. Fogelman, M. Maisey, A. Rodin, 1989 .

Predicting the Risk of Fracture at Any Site in the Skeleton: Are All Bone Mineral Density Measurement Sites Equally Effective?

T. Spector, K. Knapp, G. Blake, 2005, Calcified Tissue International.

Interesting Signs in Nuclear Medicine.

I. Fogelman, G. Gnanasegaran, K. Agrawal, 2015, Seminars in nuclear medicine.

Pathophysiology, risk factors and management of bisphosphonate-associated osteonecrosis of the jaw: Is there a diverse relationship of amino- and non-aminobisphosphonates?

M. Aapro, K. Väänänen, L. Pylkkänen, 2007, Critical reviews in oncology/hematology.

Nuclear medicine studies in metabolic bone disease.

S. Hain, I. Fogelman, 2002, Seminars in musculoskeletal radiology.

The role of bone scanning in osteomalacia.

W. Greig, J. Mckillop, I. Fogelman, 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Prostate cancer: role of SPECT and PET in imaging bone metastases.

Mohsen Beheshti, I. Fogelman, M. Beheshti, 2009, Seminars in nuclear medicine.

The role of fluorodeoxyglucose, 18F-dihydroxyphenylalanine, 18F-choline, and 18F-fluoride in bone imaging with emphasis on prostate and breast.

I. Fogelman, W. Langsteger, M. Heinisch, 2006, Seminars in nuclear medicine.

The effect of nitrogen containing bisphosphonates, zoledronate and alendronate, on the production of pro-angiogenic factors by osteoblastic cells.

B. Evans, C. Elford, I. Fogelman, 2015, Cytokine.

Reduced bone density and osteoporosis associated with a polymorphic Sp1 binding site in the collagen type I α 1 gene

S. Grant, D. Reid, S. Ralston, 1996, Nature Genetics.

Chest pain in patients with normal coronary arteriograms

J. Mckillop, I. Fogelman, 1984 .

Autoparathyroidectomy: A case report

I. Fogelman, G. McLatchie, E. W. Morris, 1979, The British journal of surgery.

Extra-articular features of benign joint hypermobility syndrome.

J. Chambers, R. Grahame, G. Jackson, 1996, British journal of rheumatology.

Pitfalls and Limitations of Radionuclide Planar and Hybrid Bone Imaging.

I. Fogelman, G. Gnanasegaran, F. Marafi, 2015, Seminars in nuclear medicine.

Scintigraphic evaluation of the painful prosthetic joint: a comparison of gallium-67 citrate and indium-111 labelled leucocyte imaging.

R D Sturrock, J. Mckillop, I. Fogelman, 1984, Clinical radiology.

Periprosthetic bone remodelling of two types of uncemented femoral implant with proximal hydroxyapatite coating: a 3-year follow-up study addressing the influence of prosthesis design and preoperative bone density on periprosthetic bone loss

T. Gosens, G. Blake, I. Fogelman, 2004, Osteoporosis International.

18F-NaF PET/CT: EANM procedure guidelines for bone imaging

F. Mottaghy, S. Fanti, F. Giammarile, 2015, European Journal of Nuclear Medicine and Molecular Imaging.

The role of 99mTc-diphosphonate bone SPECT/CT in the ankle and foot

I. Fogelman, G. Gnanasegaran, S. Vijayanathan, 2012, Nuclear medicine communications.

SPECT/CT of Femeroacetabular Impingement

I. Fogelman, Allen A. Lee, H. Van der Wall, 2008, Clinical nuclear medicine.

Additional benefit of SPECT-CT in investigating heel pain.

I. Fogelman, G. Gnanasegaran, T. Barwick, 2008, Clinical nuclear medicine.

Lateral collateral ligament tear of the knee: appearances on bone scintigraphy with single-photon emission tomography

G. Cook, I. Fogelman, 1996, European Journal of Nuclear Medicine.

SPECT Imaging in the Diagnosis of Meniscal Tears

I. Fogelman, P. Ryan, P. Allen, 1993, Journal of the Royal Society of Medicine.

A comparison of MRI and bone SPET in the diagnosis of knee pathology

I. Fogelman, P. Ryan, R. Chauduri, 1996, Nuclear medicine communications.

Normal variants, artefacts and interpretative pitfalls in PET imaging with 18-fluoro-2-deoxyglucose and carbon-11 methionine

Michael N. Maisey, Gary J. R. Cook, G. Cook, 1999, European Journal of Nuclear Medicine.

Value of Lateral Blood Pool Imaging in Patients With Suspected Stress Fractures of the Tibia

I. Fogelman, S. Clarke, H. Mohan, 2011, Clinical nuclear medicine.

Diagnosis of infection in the diabetic foot using 18F‐FDG PET/CT: a sweet alternative?

I. Fogelman, G. Gnanasegaran, S. Vijayanathan, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

PET Imaging of the Skeleton

G. Cook, O. Israel, I. Fogelman, 2006 .

1, 2, 3, or 4 phase bone imaging--how many are necessary?

I. Fogelman, 1990, Nuclear medicine communications.

Evaluation of Osteoporosis Using Skin Thickness Measurements

G. Blake, I. Fogelman, R. Patel, 2007, Calcified Tissue International.

Combined phlebography and arthrography in patients with painful swollen calf.

C. Forbes, J. Belch, I. Fogelman, 1981, British medical journal.

The Localisation of Parathyroid Tumours—A Comparison of Computed Tomography with Cervical Vein Hormone Assay

I. Fogelman, G. Beastall, N. McMillan, 1983, Scottish medical journal.

[11C]Methionine positron emission tomography for patients with persistent or recurrent hyperparathyroidism after surgery.

J. Wong, I. Fogelman, M. Maisey, 1998, European journal of endocrinology.

Pitfalls and Limitations of Radionuclide Imaging in Endocrinology.

I. Fogelman, G. Gnanasegaran, B. Mittal, 2015, Seminars in nuclear medicine.

Successful repeat transcatheter ablation of a mediastinal parathyroid adenoma 6 years after alcohol embolization

G. Cook, I. Fogelman, J. Reidy, 1997, CardioVascular and Interventional Radiology.

Ablation of mediastinal parathyroid adenomas by superselective embolization of the internal mammary artery with alcohol.

J. Lewis, I. Fogelman, P. Ryan, 1993, Clinical radiology.

Pre-Operative Localisation of Parathyroid Tumours Using Neck Vein Catheterisation and Radioimmunoassay for Parathyroid Hormone: The Glasgow Experience

B. Boyce, I. Fogelman, R. Cowan, 1983, Scottish medical journal.

The role of positron emission tomography in skeletal disease.

I. Fogelman, G. Cook, 2001, Seminars in nuclear medicine.

An atlas of planar and SPECT bone scans

Lawrence E. Holder, L. Holder, I. Fogelman, 1989 .

Bone Scanning in Clinical Practice

I. Fogelman, Ignac Fogelman, 2012, Springer London.

The Evaluation of Vertebral Fracture Assessment and Pulse Wave Velocity for the Assessment of Abdominal Aortic Calcification by Comparison to Computed Tomography

I. Fogelman, M. Frost, 2018 .

Quantitative Trait Loci for Bone Lengths on Chromosome 5 Using Dual Energy X-Ray Absorptiometry Imaging in the Twins UK Cohort

T. Spector, K. Ahmadi, B. Kato, 2008, PloS one.

Biochemical prediction of response of bone metastases to treatment.

D. W. Moss, R. Rubens, R. Coleman, 1988, British Journal of Cancer.

Quantitative studies of bone with the use of 18F-fluoride and 99mTc-methylene diphosphonate.

G. Blake, I. Fogelman, S. Park-Holohan, 2001, Seminars in nuclear medicine.

Treatment of post-menopausal osteoporosis: beyond bisphosphonates

I. Fogelman, G. Hampson, S. Ishtiaq, 2014, Journal of Endocrinological Investigation.

Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study.

J. Cuzick, W. Sauerbrei, R. Blamey, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The ZEBRA study: Reversibility of bone mineral density of pre-/perimenopausal patients with node-positive early breast cancer after treatment with Zoladex™

G. Blake, I. Fogelman, 2001 .

Circulating concentrations of vitamin E isomers: Association with bone turnover and arterial stiffness in post-menopausal women.

I. Fogelman, M. Frost, K. Voong, 2015, Bone.

Diphosphonates in the evaluation of metabolic bone disease

I. Fogelman, M. Smith, M. Smith, 1982, Clinical Rheumatology.

Semi-quantitative interpretation of the bone scan in metabolic bone disease

D. Citrin, I. Fogelman, I. Hay, 1979, European Journal of Nuclear Medicine.

A comparison of bone scanning and radiology in the evaluation of patients with metabolic bone disease.

I. Fogelman, D. Carr, 1980, Clinical radiology.

Bone scan findings in hypervitaminosis D: case report.

W. Greig, B. Boyce, J. Mckillop, 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Absent kidney sign associated with symmetrical and uniformly increased uptake of radiopharmaceutical by the skeleton

W. Greig, J. Mckillop, I. Fogelman, 1977, European Journal of Nuclear Medicine.

Metabolic disturbances identified by SPECT-CT in patients with a clinical diagnosis of sacroiliac joint incompetence

I. Fogelman, M. Cusí, H. Van der Wall, 2012, European Spine Journal.

Isotope imaging.

I. Fogelman, P. Ryan, 1996, Baillière's Clinical Rheumatology.

The bone scan: where are we now?

I. Fogelman, P. Ryan, Paul J. Ryan, 1995, Seminars in nuclear medicine.

Osteoporotic vertebral fractures: diagnosis with radiography and bone scintigraphy.

I. Fogelman, P. Ryan, 1994, Radiology.

Hybrid Imaging in the Management of Complex Foot and Ankle Problems

I. Fogelman, S. Vijayanathan, H. Mohan, 2012 .

A dose-controlled study of Sm-153 -EDTMP in the treatment of patients with painful bone metastases

J. Chatal, I. Fogelman, A. Pecking, 1997 .

Whole body retention of diphosphonate in rheumatoid arthritis.

I. Fogelman, R. Sturrock, M. Steven, 1982, The Journal of rheumatology.

Chronic low back pain: comparison of bone SPECT with radiography and CT.

I. Fogelman, P. Ryan, P. Evans, 1992, Radiology.

A critical assessment of bone scan quantitation (bone to soft tissue ratios) in the diagnosis of metabolic bone disease

I. Fogelman, R. Bessent, D. Gordon, 1981, European Journal of Nuclear Medicine.

Estimation of skeletal involvement in primary hyperparathyroidism. Use of 24-hour whole-body retention of technetium-99m diphosphonate.

I. Fogelman, G. Beastall, R. Bessent, 1980, Annals of internal medicine.

I. Fogelman, R. Bessent, 1982, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Relative distribution of diphosphonate between bone and soft tissue at 4 and 24 hours: concise communication.

I. Fogelman, W. Martin, R. Bessent, 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.

D. Pearson, I. Fogelman, M. Francis, 1981, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Radionuclide Scintigraphy in Metabolic Bone Disease

G. Cook, I. Fogelman, G. Gnanasegaran, 2013 .

Pseudofracture of the ribs detected by bone scanning.

W. Greig, J. Mckillop, I. Fogelman, 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

The effect of parathyroid hormone on technetium-99m pyrophosphate distribution in rats

I. Fogelman, R. Bessent, 2004, European Journal of Nuclear Medicine.

Semi-quantitative analysis of the bone scan in acromegaly: correlation with human growth hormone values.

D. Citrin, I. Fogelman, I. Hay, 1980, The British journal of radiology.

An Atlas of Clinical Nuclear Medicine

I. Fogelman, M. Maisey, 2014 .

Paget's disease--five years follow up after pamidronate therapy.

I. Fogelman, P. Ryan, 1994, British journal of rheumatology.

Sacroiliac quantitative bone scintigraphy in ankylosing spondylitis: any clinical relevance?

I. Fogelman, P. Ryan, 1993, Nuclear medicine communications.

A single plasma sample method to assess disease activity in patients with bone metastases from carcinoma of the prostate.

I. Fogelman, M. Maisey, C. Lazarus, 1986, British journal of urology.

Skeletal uptake of Tc-99m HEDP in primary hyperparathyroidism.

W. Greig, I. Fogelman, R. Bessent, 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

A clinical comparison of 2 h and 4 h bone scans obtained with 99mTc H.E.D.P.

W. Greig, D. Citrin, J. Mckillop, 2004, European Journal of Nuclear Medicine.

SKELETAL UPTAKE OF DIPHOSPHONATE Method for Prediction of Post-menopausal Osteoporosis

R. Lindsay, I. Fogelman, R. Bessent, 1980, The Lancet.

Back pain: Can we make a contribution?

G. Cook, I. Fogelman, T. Gibson, 1997, European Journal of Nuclear Medicine.

The relationship between plasma estradiol and the increase in bone density in postmenopausal women after treatment with subcutaneous hormone implants

M. Savvas, J. Studd, I. Fogelman, 1991 .

Circulating Sclerostin and Dickkopf-1 (DKK1) in Predialysis Chronic Kidney Disease (CKD): Relationship with Bone Density and Arterial Stiffness

W. Fraser, D. Goldsmith, I. Fogelman, 2012, Calcified Tissue International.

Bone scintigraphy: Part 3. Bone scanning in metabolic bone disease.

M. Brown, I. Fogelman, B. Collier, 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Osteopetrosis: Radiological and Radionuclide Imaging

I. Fogelman, G. Gnanasegaran, K. Agrawal, 2022 .

Assessment of synthetic steroid (Org OD 14): effect on skeletal metabolism by 24-h whole-body retention of diphosphonate.

R. Lindsay, I. Fogelman, R. Bessent, 1981, Maturitas.

Increase in bone mass after one year of percutaneous oestradiol and testosterone implants in post-menopausal women who have previously received long-term oral oestrogens.

M. Savvas, J. Studd, I. Fogelman, 1993, British journal of obstetrics and gynaecology.

Glucocorticoids and æstrogens in the management of hypercalcaemia

I. Fogelman, I. Boyle, 1980 .

ABSORPTION OF ORAL DIPHOSPHONATE IN NORMAL SUBJECTS

M. A. Wilson, J. Bevan, I. Fogelman, 1986, Clinical endocrinology.

Positron emission tomography and bone metastases.

Ora Israel, Gary Cook, G. Cook, 2005, Seminars in nuclear medicine.

Strontium ranelate: a novel treatment for postmenopausal osteoporosis: a review of safety and efficacy

G. Blake, I. Fogelman, 2006, Clinical interventions in aging.

Technical principles of dual energy x-ray absorptiometry.

G. Blake, I. Fogelman, I. Fogelman, 1997, Seminars in nuclear medicine.

Role of dual-energy X-ray absorptiometry in the diagnosis and treatment of osteoporosis.

G. Blake, I. Fogelman, Ignac Fogelman, 2007, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Pregnancy in a woman with premature ovarian failure.

I. Fogelman, N. Finer, G. Bottazzo, 1985, Postgraduate medical journal.

The "hot patella" sign: is it of any clinical significance? Concise communication.

J. Mckillop, I. Fogelman, H. Gray, 1983, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging.

G. Cook, I. Fogelman, Gary J R Cook, 2004, Seminars in nuclear medicine.

The evaluation of radioiodine therapy for thyroid patients using a fixed-dose regime.

I. Fogelman, M. Maisey, G. Ratcliffe, 1986, The British journal of radiology.

Too much heparin: possible source of error in blood gas analysis.

A. Hutchison, I. Fogelman, S. H. Ralston, 1983, British medical journal.

Patterns, variants, artifacts, and pitfalls in conventional radionuclide bone imaging and SPECT/CT.

Gary Cook, Gopinath Gnanasegaran, G. Cook, 2009, Seminars in nuclear medicine.

Bone single-photon emission tomography in recent meniscal tears: an assessment of diagnostic criteria

I. Fogelman, P. Ryan, P. Allen, 1993, European Journal of Nuclear Medicine.

The role of thyroid scanning in hyperthyroidism

I. Fogelman, M. Maisey, S. Cooke, 2004, European Journal of Nuclear Medicine.

Precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism

M. Siddique, Y. Al-Beyatti, G. Blake, 2012, Osteoporosis International.

Strontium ranelate for the treatment of osteoporosis

G. Blake, I. Fogelman, 2005, BMJ : British Medical Journal.

Polymorphisms in the P450 c17 (17-hydroxylase/17,20-Lyase) and P450 c19 (aromatase) genes: association with serum sex steroid concentrations and bone mineral density in postmenopausal women.

S. Ralston, A. Wierzbicki, K. Knapp, 2004, The Journal of clinical endocrinology and metabolism.

Aortic distensibility in post-menopausal women receiving Tibolone.

K. D. Hopkins, E. Lehmann, R. Gosling, 1994, British Journal of Radiology.

Different approaches to bone densitometry.

G. Blake, I. Fogelman, G M Blake, 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Intersite comparison of the Hologic QDR-1000 dual energy X-ray bone densitometer.

G. Blake, I. Fogelman, G M Blake, 1991, The British journal of radiology.

Risedronate reverses bone loss in postmenopausal women with low bone mass: results from a multinational, double-blind, placebo-controlled trial. BMD-MN Study Group.

J. Reginster, I. Fogelman, C. Ribot, 2000, The Journal of clinical endocrinology and metabolism.

Morphometric X-ray Absorptiometry and Morphometric Radiography of the Spine: A Comparison of Analysis Precision in Normal and Osteoporotic Subjects

G. M. Blake, P. Steiger, H. K. Genant, 1999, Osteoporosis International.

Quantitative studies of bone in postmenopausal women using (18)F-fluoride and (99m)Tc-methylene diphosphonate.

G. Blake, I. Fogelman, S. Park-Holohan, 2002, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Conventional Nuclear Medicine and Hybrid Imaging in Monitoring the Treatment of Skeletal Malignancy

G. Cook, I. Fogelman, G. Gnanasegaran, 2012 .

A comparison of the effects of raloxifene and conjugated equine estrogen on bone and lipids in healthy postmenopausal women.

I. Reid, R. Eastell, N. Watts, 2004, Archives of internal medicine.

Management of male osteoporosis: report of the UK Consensus Group.

C. Cooper, R. Francis, R. Eastell, 1998, QJM : monthly journal of the Association of Physicians.

Obesity increases precision errors in total body dual-energy x-ray absorptiometry measurements.

K. Knapp, J. Welsman, G. Blake, 2015, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

How Important Are BMD Accuracy Errors for the Clinical Interpretation of DXA Scans?

G. Blake, I. Fogelman, 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A longitudinal study of supine lateral DXA of the lumbar spine: A comparison with posteroanterior spine, hip and total-body DXA

G. Blake, I. Fogelman, R. Herd, 1996, Osteoporosis International.

Hormone Replacement Therapy Versus the Combined Oral Contraceptive Pill in Premature Ovarian Failure: A Randomized Controlled Trial of the Effects on Bone Mineral Density.

P. Seed, I. Fogelman, J. Rymer, 2016, The Journal of clinical endocrinology and metabolism.

Bone scintigraphy predicts outcome of steroid injection for plantar fasciitis.

I. Fogelman, H. Van der Wall, L. Emmett, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Bone density in users of combined oral contraception. Preliminary reports of a pilot study.

I. Fogelman, A. Rodin, M. Chapman, 1991 .

Efficacy of tibolone as "add-back therapy" in conjunction with a gonadotropin-releasing hormone analogue in the treatment of uterine fibroids.

I. Fogelman, J. Rymer, E. Morris, 2008, Fertility and sterility.

Can the WHO Criteria for Diagnosing Osteoporosis be Applied to Calcaneal Quantitative Ultrasound?

G. Blake, I. Fogelman, M. Frost, 2000, Osteoporosis International.

Lesions in the ribs detected by bone scanning.

I. Fogelman, 1980, Clinical Radiology.

Visual Assessment of Vertebral Deformity by X-ray Absorptiometry: A Highly Predictive Method to Exclude Vertebral Deformity

G. M. Blake, P. Steiger, H. K. Genant, 2000, Osteoporosis International.

Morphometric X‐Ray Absorptiometry: Reference Data for Vertebral Dimensions

G. Blake, I. Fogelman, P. Steiger, 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Comparison of six quantitative methods for the measurement of bone turnover at the hip and lumbar spine using 18F-fluoride PET-CT

Musib Siddique, P. Marsden, M. Siddique, 2012, Nuclear medicine communications.

Significant differences in UK and US female bone density reference ranges

J. Cuzick, A. Howell, R. Eastell, 2010, Osteoporosis International.

Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action?

C. Cooper, R. Francis, R. Eastell, 2001, QJM : monthly journal of the Association of Physicians.

OSTEOPOROSIS: A GROWING EPIDEMIC

I. Fogelman, P. Ryan, 1991, The British journal of clinical practice.

Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.

G. Blake, I. Fogelman, A. Moore, 2009, Seminars in nuclear medicine.

Accuracy of 24-h whole-body (skeletal) retention of diphosphonate measurements

I. Fogelman, R. Bessent, J. Scullion, 2004, European Journal of Nuclear Medicine.

Differences in regional bone perfusion and turnover between lumbar spine and distal humerus: (18)F-fluoride PET study of treatment-naïve and treated postmenopausal women.

P. Marsden, G. Cook, G. Blake, 2009, Bone.

Quantitative PET Imaging Using (18)F Sodium Fluoride in the Assessment of Metabolic Bone Diseases and the Monitoring of Their Response to Therapy.

M. Siddique, G. Blake, I. Fogelman, 2012, PET clinics.

THE VALUE OF 24 HOUR SKELETAL UPTAKE OF DIPHOSPHONATE IN THE EXCLUSION OF METABOLIC BONE DISEASE

I. Fogelman, 1980 .

The localization of myocardial ischaemia with technetium-99m methoxy isobutyl isonitrile and single photon emission computed tomography.

I. Fogelman, M. Maisey, R. Mistry, 1989, The British journal of radiology.

Breast cancer and osteoporosis--a bridge at last.

I. Fentiman, I. Fogelman, 1993, European journal of cancer.

Changes in bone mineral density and bone turnover in patients on ‘drug holiday’ following bisphosphonate therapy: real‐life clinic setting

I. Fogelman, A. Moore, G. Hampson, 2016, Clinical endocrinology.

Methods and Clinical Issues in Bone Densitometry

G. Blake, I. Fogelman, 2008 .

A review of strontium ranelate and its effect on DXA scans.

E. Lewiecki, G. Blake, I. Fogelman, 2007, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

The relationship between regional bone turnover measured using 18F-fluoride positron emission tomography and changes in BMD is equivalent to that seen for biochemical markers of bone turnover.

Paul K Marsden, P. Marsden, G. Cook, 2007, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Bone densitometry: an update

G. Blake, I. Fogelman, 2005, The Lancet.

Fracture Prediction by Bone Density Measurements at Sites Other than the Fracture Site: the Contribution of BMD Correlation

G. Blake, I. Fogelman, 2005, Calcified Tissue International.

An evaluation of the United Kingdom National Osteoporosis Society position statement on the use of peripheral dual-energy X-ray absorptiometry

G. Blake, I. Fogelman, R. Patel, 2004, Osteoporosis International.

DXA scanning and its interpretation in osteoporosis.

G. Blake, I. Fogelman, Ignac Fogelman, 2003, Hospital medicine.

Applications of bone densitometry for osteoporosis.

G. Blake, I. Fogelman, 1998, Endocrinology and metabolism clinics of North America.

Peripheral or axial bone density measurements?

G. Blake, I. Fogelman, R. Patel, 1998, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

Bone densitometry: current status and future prospects.

C C Glüer, C. Glüer, G. Blake, 1997, The British journal of radiology.

The Effect of Weight Change on DXA Scans in a 2-Year Trial of Etidronate Therapy

G. Blake, I. Fogelman, R. Herd, 1997, Calcified Tissue International.

Intervertebral T-score differences in younger and older women.

T. Spector, G. Blake, I. Fogelman, 2013, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

(18)F-Fluoride PET in Osteoporosis.

G. Blake, I. Fogelman, M. Frost, 2010, PET clinics.

99mTc-sestamibi and minimally invasive radioguided surgery for primary hyperparathyroidism.

H. Carmalt, I. Fogelman, H. Van der Wall, 2005, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Tuberculosis of the Spine on Tc-99m MDP Bone Scan: Additional Role of SPECT-CT

I. Fogelman, G. Gnanasegaran, T. Barwick, 2009, Clinical nuclear medicine.

The Use of F-18 Choline PET in the Assessment of Bone Metastases in Prostate Cancer: Correlation with Morphological Changes on CT

P. Waldenberger, I. Fogelman, C. Pirich, 2009, Molecular Imaging and Biology.

Interpretation of bone densitometry studies.

G. Blake, I. Fogelman, G M Blake, 1997, Seminars in nuclear medicine.

Bone density of normal women in relation to endogenous and exogenous oestrogens.

I. Fentiman, B. D. De Stavola, I. Fogelman, 1994, British Journal of Rheumatology.

Non-invasive assessment of skeletal kinetics using fluorine-18 fluoride positron emission tomography: evaluation of image and population-derived arterial input functions

Martin A. Lodge, Paul K. Marsden, Gary J. R. Cook, 1999, European Journal of Nuclear Medicine.

Relationship of Calcification of Atherosclerotic Plaque and Arterial Stiffness to Bone Mineral Density and Osteoprotegerin in Postmenopausal Women Referred for Osteoporosis Screening

P. Chowienczyk, S. Millasseau, I. Fogelman, 2008, Calcified Tissue International.

The evaluation of osteoporosis : dual energy x-ray absorptiometry in clinical practice

H. Wahner, I. Fogelman, Heinz W. Wahner, 1994 .

Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women.

J. Robinson, I. Fogelman, J. Rymer, 2002, Climacteric : the journal of the International Menopause Society.

Comparison of myocardial gated single photon emission computerised tomography, planar radionuclide ventriculography and echocardiography in evaluating left ventricular ejection fraction, wall thickening and wall motion

L. Livieratos, I. Fogelman, J. Chambers, 2004, International journal of clinical practice.

HYPERCALCAEMIA AND METASTATIC BONE DISEASE: IS THERE A CAUSAL LINK?

S. Ralston, I. Fogelman, M. D. Gardner, 1982, The Lancet.

Correlation of skeletal uptake of 99mTc-diphosphonate and alkaline phosphatase before and after oral diphosphonate therapy in Paget's disease.

S. Ralston, B. Boyce, I. Fogelman, 1984, Metabolic bone disease & related research.

Multisite Quantitative Ultrasound: Precision, Age- and Menopause-Related Changes, Fracture Discrimination, and T-score Equivalence with Dual-Energy X-ray Absorptiometry

G. M. Blake, T. Spector, K. Knapp, 2001, Osteoporosis International.

Spine and femur BMD by DXA in patients with varying severity spinal osteoporosis

G. Blake, I. Fogelman, R. Herd, 1993, Calcified Tissue International.

Quantitative Ultrasound and Bone Mineral Density Are Equally Strongly Associated with Risk Factors for Osteoporosis

G. Blake, I. Fogelman, M. Frost, 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Long term compliance with hormone replacement treatment following screening for postmenopausal osteoporosis by bone density measurements

G. Blake, I. Fogelman, P. Ryan, 1996 .

Relative contribution of humoral and metastatic factors to the pathogenesis of hypercalcaemia in malignancy.

S. Ralston, I. Fogelman, M. Gardiner, 1984, British medical journal.

Parathyroid Hormone(1–84) Treatment of Postmenopausal Women with Low Bone Mass Receiving Hormone Replacement Therapy

T. Spector, C. Christiansen, W. Fraser, 2008, Calcified Tissue International.

Changes in QUS and BMD Measurements with Antiresorptive Therapy: A Two-Year Longitudinal Study

G. Blake, I. Fogelman, M. Frost, 2001, Calcified Tissue International.

Atypical Paget's Disease With Quantitative Assessment of Tracer Kinetics

G. Blake, I. Fogelman, G. Gnanasegaran, 2007, Clinical nuclear medicine.

A semipopulation input function for quantifying static and dynamic 18F-fluoride PET scans

M. Siddique, G. Blake, I. Fogelman, 2012, Nuclear medicine communications.

Validation of image-derived arterial input functions at the femoral artery using 18F-fluoride positron emission tomography

P. Marsden, M. Siddique, K. Curran, 2011, Nuclear medicine communications.

A direct in vivo measurement of 99mTc‐methylene diphosphonate protein binding

G. Blake, I. Fogelman, S. Park-Holohan, 2003, Nuclear medicine communications.

Assessment of skeletal uptake of99mTc-diphosphonate over a five day period

I. Fogelman, W. Martin, 2004, European Journal of Nuclear Medicine.

Clinical evaluation of a phalangeal bone mineral density assessment system.

E. Panayiotou, G. Blake, I. Fogelman, 2010, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

In-vivo cross-calibration of a new peripheral densitometer: The Osteometer Dexacare G4.

G. Blake, I. Fogelman, R. Patel, 2003 .

Long-Term Precision of 18F-Fluoride PET Skeletal Kinetic Studies in the Assessment of Bone Metabolism

P. Marsden, G. Cook, K. Curran, 2008, Journal of Nuclear Medicine.

Does Quantitative Ultrasound Imaging Enhance Precision and Discrimination?

G. Blake, I. Fogelman, M. Frost, 2000, Osteoporosis International.

Chapter 32. Radionuclide Scintigraphy in Metabolic Bone Disease

G. Cook, I. Fogelman, G. Gnanasegaran, 2009 .

Contact Quantitative Ultrasound: An Evaluation of Precision, Fracture Discrimination, Age-Related Bone Loss and Applicability of the WHO Criteria

G. Blake, I. Fogelman, M. Frost, 1999, Osteoporosis International.

Bone densitometry: an update References for figures

G. Blake, I. Fogelman, 2005 .

Bone Densitometry, X-Ray and Quantitative Ultrasound

G. Blake, I. Fogelman, 1998 .

Optimizing data acquisition and analysis of morphometric X-ray absorptiometry

G. Blake, I. Fogelman, P. Steiger, 2007, Osteoporosis International.

Bone mineral measurements in clinical practice.

I. Fogelman, B. Murby, 1987, British journal of hospital medicine.

Distribution of bone mineral density in the lumbar spine in health and osteoporosis

G. Blake, I. Fogelman, R. Herd, 1994, Osteoporosis International.

Short communication: spinal bone density measured with a 5 s scan.

G. Blake, I. Fogelman, J. Parker, 1993, The British journal of radiology.

Re: Thyroid Carcinoma in an Autonomously Functioning Nodule

I. Fogelman, R. Bessent, 1980 .

PATHOGENESIS OF OSTEOPOROSIS

B. Boyce, I. Fogelman, I. Boyle, 1980, The Lancet.

Effect of increasing vertebral marrow fat content on BMD measurement, T-Score status and fracture risk prediction by DXA.

D. Yeung, J. Griffith, P. Leung, 2009, Bone.

Dual X-ray absorptiometry: a comparison between fan beam and pencil beam scans.

G. Blake, I. Fogelman, J. Parker, 1993, The British journal of radiology.

Combined oral contraception and skeletal bone mass

I. Fogelman, A. Rodin, M. Chapman, 1987 .

Strontium does accumulate in bone

G. Blake, I. Fogelman, 2012, Osteoporosis International.

Renal excretion of technetium-99m diphosphonate in osteomalacia.

I. Fogelman, R. Bessent, 1979, Annals of internal medicine.

Recent advances in bone densitometry

G. Blake, I. Fogelman, 1993, European Journal of Nuclear Medicine.

A study to determine the dependence of 99mTc-MDP protein binding on plasma clearance and serum albumin concentration

G. Blake, I. Fogelman, A. Moore, 2007, Nuclear medicine communications.

Quantitative dynamic bone SPECT: A new method to assess skeletal kinetics.

D. Bailey, G. Cook, S. Hain, 2003 .

A comparison of fracture discrimination using calcaneal quantitative ultrasound and dual X-ray absorptiometry in women with a history of fracture at sites other than the spine and hip

G. Blake, I. Fogelman, M. Frost, 2002, Calcified Tissue International.

Correction to: 18F-NaF PET/CT: EANM procedure guidelines for bone imaging

F. Mottaghy, S. Fanti, B. Krause, 2018, European Journal of Nuclear Medicine and Molecular Imaging.

Estimation of regional bone metabolism from whole-body 18F-fluoride PET static images

P. Marsden, M. Siddique, G. Blake, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

The Precision and Sensitivity of 18F-Fluoride PET for Measuring Regional Bone Metabolism: A Comparison of Quantification Methods

Paul J Schleyer, Paul K Marsden, Musib Siddique, 2011, The Journal of Nuclear Medicine.

Dual X-ray absorptiometry: a comparison between fan beam and pencil beam scans

Glen M. Blake, G. Blake, I. Fogelman, 1993 .

Dual energy x-ray absorptiometry: the effects of beam hardening on bone density measurements.

G. Blake, I. Fogelman, P. Ryan, 1992, Medical physics.

Correcting 18F-fluoride PET static scan measurements of skeletal plasma clearance for tracer efflux from bone

M. Siddique, G. Blake, I. Fogelman, 2014, Nuclear medicine communications.

A Method for Determining Skeletal Lengths from DXA Images

T. Spector, G. Blake, I. Fogelman, 2007, BMC musculoskeletal disorders.

The effect of weight and weight change on the long-term precision of spine and hip DXA measurements

J. Robinson, G. Blake, I. Fogelman, 2011, Osteoporosis International.

The effects of oestrogen deficiency on the skeleton and its prevention.

I. Fogelman, 1996, British journal of obstetrics and gynaecology.

Serial scintiscanning in breast cancer: the indications and prognostic value.

W. Greig, D. Citrin, J. Mckillop, 1980, Clinical oncology.

Recognition of the femoroacetabular impingement syndrome on MDP SPECT CT.

I. Fogelman, G. Gnanasegaran, N. Mulholland, 2008, Clinical nuclear medicine.

Late Low‐Dose Steroid Withdrawal in Renal Transplant Recipients Increases Bone Formation and Bone Mineral Density

I. Fogelman, R. Hilton, S. Sacks, 2006, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Comparison of ordered-subset expectation maximization and filtered back projection reconstruction based on quantitative outcome from dynamic [18F]NaF PET images

M. Siddique, G. Blake, I. Fogelman, 2021, Nuclear medicine communications.

Safety and efficacy of PTH(1-84) at 18 and 24 months in women with postmenopausal osteoporosis receiving hormone therapy: Results from the POWER study

T. Spector, C. Christiansen, W. Fraser, 2005 .

Risedronate produces dose-dependent increases in bone mineral density in postmenopausal women with low bone mass

J. Reginster, P. Bettica, I. Fogelman, 1999 .

Updated survival results from the Zebra trial.

J. Cuzick, W. Sauerbrei, M. Schumacher, 2002 .

Comparison of clinical, radionuclide, and radiographic features of osteoarthritis of the hands.

J. Lynch, J. Buckland-Wright, P. Emery, 1991, Annals of the rheumatic diseases.

Development of a phantom for morphometric X-ray absorptiometry.

G. Blake, I. Fogelman, J. Rea, 2001, The British journal of radiology.

Vitamin D Status and Parathyroid Hormone Concentrations Influence the Skeletal Response to Zoledronate and Denosumab

I. Fogelman, A. Moore, G. Hampson, 2014, Calcified Tissue International.

Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer

O. Israel, I. Fogelman, A. Frenkel, 2016, Nuclear medicine communications.

Circulating Sclerostin and Dickkopf-1 (DKK1) in Predialysis Chronic Kidney Disease (CKD): Relationship with Bone Density and Arterial Stiffness

W. Fraser, D. Goldsmith, I. Fogelman, 2012, Calcified Tissue International.

OD14 — Bone protection with no endometrial stimulation

I. Fogelman, J. Rymer, M. Chapman, 1992 .

Pseudo pulmonary embolism in complex congenital heart disease.

I. Fogelman, G. Cook, 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Pregnancy inawomanwith premature ovarian failure

I. Fogelman, N. Finer, 1985 .

The thyroid scan in Hashimoto's thyroiditis: the great mimic

I. Fogelman, M. Maisey, S. Clarke, 1988, Nuclear medicine communications.

Measurements of broadband ultrasonic attenuation in the calcaneus in premenopausal and postmenopausal women

G. Blake, I. Fogelman, R. Herd, 1992, Osteoporosis International.

Oral surgery: ARONJ masterclass

I. Fogelman, T. Renton, S. Popat, 2014, BDJ.

92149358 Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis

G. Blake, I. Fogelman, P. Ryan, 1992 .

Sacroiliac steroid injections do not predict ablation relief-not a surprise.

I. Fogelman, M. Cusí, H. Van der Wall, 2013, Pain medicine.

Bisphosphonates and vertebral fracture: An epidemiological perspective

C. Cooper, L. Melton, I. Fogelman, 2005, Osteoporosis International.

The effect of 1 alpha-hydroxyvitamin D3 on the mineralization defect in disodium etidronate-treated Paget's disease--a double-blind randomized clinical study.

S. Ralston, B. Boyce, I. Fogelman, 1987, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

The Effect of Weight Change on Total Body Dual-Energy X-ray Absorptiometry: Results from a Clinical Trial

G. Blake, I. Fogelman, R. Herd, 2000, Osteoporosis International.

Relative Contribution of Humoral and Metastatic Factors to the Pathogenesis of Hypercalcaemia and Malignancy

S. Ralston, I. Fogelman, M. Gardiner, 1984 .

Vertebral Morphometry: A Comparison of Long-Term Precision of Morphometric X-ray Absorptiometry and Morphometric Radiography in Normal and Osteoporotic Subjects

J. Li, H. Genant, G. Blake, 2001, Osteoporosis International.

Minimum effective dose of estrogen for protection against post menopausal bone loss

R. Lindsay, I. Fogelman, D. Hart, 1982 .

Dual Energy X-Ray Absorptiometry and Its Clinical Applications

G. Blake, I. Fogelman, Ignac Fogelman, 2002, Seminars in musculoskeletal radiology.

Erratum to: The Use of F-18 Choline PET in the Assessment of Bone Metastases in Prostate Cancer: Correlation with Morphological Changes on CT

P. Waldenberger, I. Fogelman, C. Pirich, 2010, Molecular Imaging and Biology.

Risedronate increases bone mineral density and is well-tolerated in postmenopausal women with low bone mineral density

J. Reginster, P. Bettica, I. Fogelman, 1999 .

Exercise myocardial perfusion scintigraphy with technetium-99m methoxy isobutylisonitrile: a comparative study with thallium-201.

E. Sowton, I. Fogelman, M. Maisey, 1990, International journal of cardiology.

‘Sink or swim’: an evaluation of the clinical characteristics of individuals with high bone mass

E. McCloskey, G. Davey-Smith, E. Duncan, 2011, Osteoporosis International.

Tampon-Associated Toxic Shock Syndrome—A Case Report

I. Fogelman, C. Semple, 1981, Scottish medical journal.

Detection of an Elusive Osteoid Osteoma Using a Registration Bone Scan

D. Evans, Y. Wilson, I. Fogelman, 1997, Journal of hand surgery.

Prospective comparison of whole-body bone SPECT and sodium 18F-fluoride PET in the detection of bone metastases from breast cancer

O. Israel, I. Fogelman, A. Frenkel, 2016, Nuclear medicine communications.

Thiazide diuretics and osteoporosis

I. Fogelman, 1991, Mayo Clinic health letter.

Ten years of treatment with tibolone 2.5 mg daily: effects on bone loss in postmenopausal women

J. Robinson, I. Fogelman, J. Rymer, 2002 .

Long-Term Precision of 18F-Fluoride PET Skeletal Kinetic Studies in the Assessment of Bone Metabolism

P. Marsden, G. Cook, K. Curran, 2008, Journal of Nuclear Medicine.

The clinical role of dual energy X-ray absorptiometry.

G. Blake, I. Fogelman, 2009, European journal of radiology.

Radionuclide and Hybrid Bone Imaging

G. Blake, I. Fogelman, 2012 .

The time of day that etidronate is ingested does not influence its therapeutic effect in osteoporosis.

G. Blake, I. Fogelman, G. Cook, 2000, Scandinavian journal of rheumatology.

Site specific measurements of bone formation using [18F] sodium fluoride PET/CT.

M. Siddique, G. Blake, I. Fogelman, 2018, Quantitative imaging in medicine and surgery.

Assessment of malignant and benign bone lesions by static F-18 Fluoride PET-CT: Additional value of SUV!

P. Waldenberger, I. Fogelman, M. Beheshti, 2008 .

Potential Applications and Limitations of SPECT-CT in Classifying Bone Lesions in Patients with Cancer

I. Fogelman, G. Gnanasegaran, T. Barwick, 2012 .

18F‐fluoride PET as a noninvasive imaging biomarker for determining treatment efficacy of bone active agents at the hip: A prospective, randomized, controlled clinical study

P. Marsden, M. Siddique, P. Schleyer, 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Another Look at the Pathogenesis of Malignancy Associated Hypercalcaemia

S. Ralston, I. Fogelman, R. Cowan, 1983 .

Osteonecrosis of the Jaw: More Heat Than Light

R. Russell, I. Fogelman, M. Pazianas, 2008, Journal of Nuclear Medicine.

The isotope bone scan: we can do better

G. Cook, G. Blake, I. Fogelman, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Comparison of six quantitative methods for the measurement of bone turnover at the hip and lumbar spine using 18F-fluoride PET-CT

P. Marsden, M. Siddique, K. Curran, 2012, Nuclear medicine communications.

Tuberculosis of the Spine on Tc-99m MDP Bone Scan: Additional Role of SPECT-CT

I. Fogelman, G. Gnanasegaran, T. Barwick, 2009, Clinical nuclear medicine.

The role of 99mTc-diphosphonate bone SPECT/CT in the ankle and foot

I. Fogelman, G. Gnanasegaran, S. Vijayanathan, 2012, Nuclear medicine communications.